|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Port Wine Stain | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Port-Wine Stain | |||||
| 3 | More general conditions related to this trial | ||||
| Congenital Abnormalities | |||||
| Skin Abnormalities | |||||
| Skin Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| topical imiquimod 5% cream | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Imiquimod | |||||
| 6 | More general drug interventions related to this trial | ||||
| Adjuvants, Immunologic | |||||
| Antineoplastic Agents | |||||
| Immunologic Factors | |||||
| Interferon Inducers | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| University of California, Irvine | |||||
| Beckman Laser Institute Medical Clinic | |||||
| Graceway Pharmaceuticals | |||||
| Sturge Weber Foundation | |||||